Testing, Treatment, and Vaccinations for MPX
Care Resource is providing testing, treatment, and vaccinations for MPX – (AKA. Monkeypox).
MPX vaccine (JYNNEOS) is available in limited supply for high-risk patients at all our health centers in Broward and Miami-Dade counties. Patients concerned about symptoms or exposure may schedule an appointment with their Care Resource Medical Provider.
Who are considered high-risk?
- Individuals that have been identified by public health officials through case investigation, contact tracing, and risk exposure assessments
- Individuals that may have had a close physical or sexual partner /contact in the past 14 days was diagnosed, or suspected of having MPX
- Individuals that have had multiple sexual partners in the past 14 days in a jurisdiction with known MPX
The MPX vaccine is currently being administered by appointment only to scheduled patients as ordered by their Medical Provider.
New and existing patients seeking an MPX vaccine ONLY, may call our appointment lines at:
- Fort Lauderdale Health Center located at 871 W Oakland Park Boulevard from 1:00pm – 5:00pm, 954-567-7141, Extension #198
New patients seeking testing and treatment for MPX must first pre-register online here
“Human-to-human transmission of MPX occurs by direct contact with lesion material or from exposure to respiratory secretions. Reports of human-to-human transmission describe close contact with an infectious person. Transmission in healthcare settings has been rarely described. Transmission of MPX requires prolonged close contact with a symptomatic individual.” Steven Santiago, MD, Chief Medical Officer.
MPX is a disease that can make you sick, including a rash, which may look like pimples or blisters, often with an earlier flu-like illness. MPX can spread to anyone through close, personal, often skin-to-skin contact. In fact, a rave, party, or club where there is minimal clothing and where there is direct, personal, often skin-to-skin contact has some risk. Some MPX symptoms include a fever, headache, muscle aches and backache, swollen lymph nodes, chills, or exhaustion. Within 1-3 days of these symptoms beginning, people develop a rash or sores. MPX can be spread from the time symptoms start until all sores, including scabs, have healed and a fresh layer of skin has formed.
“To help reduce the spread of MPX, it is important to practice good hand hygiene and use appropriate personal protective equipment to protect household members if ill or caring for ill persons at home. If one has a new or unexplained rash, sores, or other symptoms, it is important that they avoid sex or being intimate with anyone until they have been checked out by their Care Resource provider.” Sheryl Zayas, MD, Medical Director.
More information about JYNNEOS:
JYNNEOS is the vaccine indicated for prevention of smallpox and MPX in adults 18 years of age and older determined to be at high-risk for smallpox or MPX infection. Two doses of JYNNEOS are required, as this is the only FDA-approved dosing regimen.
JYNNEOS has been evaluated in clinical studies involving people with HIV infection and atopic dermatitis and shown to be safe and effective in eliciting an immune response in these populations. People who receive JYNNEOS are considered to reach maximum immunity 14 days after their second dose (6 weeks from first dose). They should continue to take precautions against monkeypox during this time. JYNNEOS may be given as standard pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP).
More information about MPX from the CDC:
- Clinician Frequently Asked Questions
- Infection Prevention and Control of Monkeypox in Healthcare Settings
- Information For Healthcare Professionals
About Care Resource:
Care Resource is a 501(c) (3) nonprofit organization and a Federally Qualified Health Center (FQHC) with four locations in Midtown Miami, Little Havana, Miami Beach, and Fort Lauderdale. The health center provides comprehensive health and support services to address the full health care needs of South Florida’s pediatric, adolescent, and adult populations.